aTyr Pharma ATYR Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $10.01M-3.4% | $10.74M-2.8% | $6.15M-46.3% | $17.22M+153% | $10.36M+52.2% | ||
| $56.51M-14.4% | $67.94M+11.3% | $84.05M+54.1% | $63.13M-11.9% | $65.99M-15.1% | ||
| $1.81M-25.8% | $2.24M-24.3% | $2.71M-7.3% | $2.88M-0.6% | $2.43M-24.3% | ||
| $586K-90.1% | $677K-91.6% | $1.77M-79.2% | $6.65M-34.7% | $5.93M-40.3% | ||
| $67.58M-18.8% | $80.24M-2.1% | $93.01M+21.9% | $87.49M-3.1% | $83.27M-14.1% | ||
| $4.24M-9.5% | $4.26M-12.1% | $4.43M-11.8% | $4.53M-12.7% | $4.68M-12.5% | ||
| $5.44M-5.4% | $5.52M-5.0% | $5.6M-4.7% | $5.68M-4.4% | $5.75M-4.2% | ||
| $148K+124% | $148K+124% | $149K+14.6% | $66K-49.2% | $66K-49.2% | ||
| $79.65M-18.1% | $93M-4.0% | $106.65M+16.4% | $101.53M-4.2% | $97.25M-14.1% | ||
| $2.76M+79.9% | $3.89M-10.0% | $4.06M+2.9% | $3.88M+209% | $1.53M-68.7% | ||
| $7.46M-5.1% | $9.79M+4.2% | $10.19M+13.7% | $10.32M+9.7% | $7.86M-21.0% | ||
| $596K+8.4% | $630K+16.5% | $630K+19.3% | $562K+8.7% | $550K+8.5% | ||
| $890K+20.3% | $836K+17.6% | $799K+17.0% | $769K+17.2% | $740K+17.6% | ||
| $596K+8.4% | $630K+16.5% | $630K+19.3% | $562K+8.7% | $550K+8.5% | ||
| $11.7M+9.5% | $15.15M+1.2% | $15.68M+11.0% | $15.53M+31.2% | $10.68M-33.1% | ||
| $10.06M-8.1% | $10.31M-7.5% | $10.53M-7.1% | $10.75M-6.7% | $10.95M-6.3% | ||
| $747K-42.4% | $889K-37.7% | $1.03M-33.9% | $1.16M-30.8% | $1.3M-28.1% | ||
| $10.95M-6.3% | $11.14M-6.0% | $11.33M-5.7% | $11.51M-5.4% | $11.69M-5.1% | ||
| $151K-79.8% | $259K-70.8% | $398K-61.3% | $602K-48.3% | $747K-42.4% | ||
| —— | —— | —— | —— | —— | ||
| $98K+10.1% | $98K+16.7% | $98K+28.9% | $93K+22.4% | $89K+30.9% | ||
| $674.86M+8.5% | $673.55M+11.9% | $672.34M+15.5% | $641.28M+10.3% | $621.95M+9.5% | ||
| -$616.96M-12.8% | -$606.16M-13.9% | -$592.2M-14.5% | -$566.46M-13.3% | -$546.93M-13.1% | ||
| -$70K-6.1% | -$8K+80.0% | -$1K-103% | -$75K+55.4% | -$66K+58.2% | ||
| -$193K-2.7% | -$192K-2.7% | -$191K-2.7% | -$189K-2.7% | -$188K-2.2% | ||
| $57.93M-22.8% | $67.48M-3.6% | $80.24M+22.8% | $74.85M-8.3% | $75.05M-11.1% | ||
| $79.65M-18.1% | $93M-4.0% | $106.65M+16.4% | $101.53M-4.2% | $97.25M-14.1% | ||
| $56.51M-14.4% | $67.94M+11.3% | $84.05M+54.1% | $63.13M-11.9% | $65.99M-15.1% | ||
| $477K-51.7% | $873K-49.7% | $1.04M-43.1% | $498K-69.4% | $988K-60.1% | ||
| $477K-51.7% | $873K-49.7% | $1.04M-43.1% | $498K-69.4% | $988K-60.1% | ||
| $148K+124% | $148K+124% | $149K+14.6% | $66K-49.2% | $66K-49.2% | ||
| $5.44M-5.4% | $5.52M-5.0% | $5.6M-4.7% | $5.68M-4.4% | $5.75M-4.2% | ||
| $5.44M-5.4% | $5.52M-5.0% | $5.6M-4.7% | $5.68M-4.4% | $5.75M-4.2% | ||
| $148K+124% | $148K+124% | $149K+14.6% | $66K-49.2% | $66K-49.2% | ||
| $5.44M-5.4% | $5.52M-5.0% | $5.6M-4.7% | $5.68M-4.4% | $5.75M-4.2% | ||
| $148K+124% | $148K+124% | $149K+14.6% | $66K-49.2% | $66K-49.2% | ||
| $7.46M-5.1% | $9.79M+4.2% | $10.19M+13.7% | $10.32M+9.7% | $7.86M-21.0% | ||
| $7.46M-5.1% | $9.79M+4.2% | $10.19M+13.7% | $10.32M+9.7% | $7.86M-21.0% | ||
| $12.3M-9.2% | $12.66M-8.4% | $12.99M-7.9% | $13.24M-7.9% | $13.54M-7.5% | ||
| $98K+10.1% | $98K+16.7% | $98K+28.9% | $93K+22.4% | $89K+30.9% | ||
| $596K+8.4% | $630K+16.5% | $630K+19.3% | $562K+8.7% | $550K+8.5% | ||
| $447K-57.1% | $596K-50.0% | $745K-44.4% | $894K-40.0% | $1.04M-36.4% | ||
| -$193K-2.7% | -$192K-2.7% | -$191K-2.7% | -$189K-2.7% | -$188K-2.2% | ||
| $586K-90.1% | $677K-91.6% | $1.77M-79.2% | $6.65M-34.7% | $5.93M-40.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are aTyr Pharma's total assets?
- aTyr Pharma (ATYR) holds $79.7M in total assets, down 18.1% year over year.
- How much debt does aTyr Pharma have?
- aTyr Pharma carries $12.3M in total debt against $57.9M of shareholders' equity, a debt-to-equity ratio of 0.21.
- How much cash does aTyr Pharma have?
- aTyr Pharma holds $10.0M in cash and equivalents.
- Can aTyr Pharma cover its short-term obligations?
- Its current ratio is 5.78 — current assets exceed current liabilities.
- Where does aTyr Pharma's balance sheet data come from?
- Every line is extracted from aTyr Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
